Edap Tms SA
NASDAQ:EDAP
Intrinsic Value
EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. [ Read More ]
The intrinsic value of one EDAP stock under the Base Case scenario is 5.23 USD. Compared to the current market price of 7.35 USD, Edap Tms SA is Overvalued by 29%.
Valuation Backtest
Edap Tms SA
Run backtest to discover the historical profit from buying and selling EDAP stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Edap Tms SA's business.
What risks and challenges
does Edap Tms SA face in the near future?
Summarize the latest earnings report
of Edap Tms SA.
Provide P/E
for Edap Tms SA and its competitors.
Balance Sheet Decomposition
Edap Tms SA
Current Assets | 80.3m |
Cash & Short-Term Investments | 47.7m |
Receivables | 16.3m |
Other Current Assets | 16.2m |
Non-Current Assets | 13m |
PP&E | 8.1m |
Intangibles | 2.4m |
Other Non-Current Assets | 2.5m |
Current Liabilities | 25.9m |
Accounts Payable | 16.9m |
Short-Term Debt | 1.6m |
Other Current Liabilities | 7.4m |
Non-Current Liabilities | 7.2m |
Long-Term Debt | 2.4m |
Other Non-Current Liabilities | 4.8m |
Earnings Waterfall
Edap Tms SA
Revenue
|
56.5m
EUR
|
Cost of Revenue
|
-33.5m
EUR
|
Gross Profit
|
23.1m
EUR
|
Operating Expenses
|
-41m
EUR
|
Operating Income
|
-17.9m
EUR
|
Other Expenses
|
-3.4m
EUR
|
Net Income
|
-21.3m
EUR
|
Free Cash Flow Analysis
Edap Tms SA
What is Free Cash Flow?
EDAP Profitability Score
Profitability Due Diligence
Edap Tms SA's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
Score
Edap Tms SA's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
EDAP Solvency Score
Solvency Due Diligence
Edap Tms SA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
Edap Tms SA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EDAP Price Targets Summary
Edap Tms SA
According to Wall Street analysts, the average 1-year price target for EDAP is 11.99 USD with a low forecast of 9.09 USD and a high forecast of 16.8 USD.
Shareholder Return
EDAP Price
Edap Tms SA
Average Annual Return | 39.36% |
Standard Deviation of Annual Returns | 32.87% |
Max Drawdown | -68% |
Market Capitalization | 271.3m USD |
Shares Outstanding | 36 927 400 |
Percentage of Shares Shorted | 0.19% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 227 full-time employees. The firm operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The firm invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The firm is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The firm is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.
Contact
IPO
Employees
Officers
The intrinsic value of one EDAP stock under the Base Case scenario is 5.23 USD.
Compared to the current market price of 7.35 USD, Edap Tms SA is Overvalued by 29%.